Cited by 205

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing: Regulated intramembrane proteolysis and APP processing

Lichtenthaler, Stefan F., Haass, Christian, Steiner, Harald·2011·Journal of Neurochemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2011.07248.x

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • After initial BACE1 cleavage, the resulting C-terminal, membrane-bound protein fragments of several membrane proteins, including APP and SEZ6L, are further processed within their transmembrane domains by γ-secretase, in a process referred to as regulated intramembrane proteolysis.

    “After initial BACE1 cleavage, the resulting C-terminal, membrane-bound protein fragments of several membrane proteins, including APP and SEZ6L [17], are further processed within their transmembrane domains by γ-secretase, in a process referred to as regulated intramembrane proteolysis [41]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 206

  1. Ahn, 2010, Activation and intrinsic γ-secretase activity of presenilin 1, Proc. Natl Acad. Sci. USA, 50, 21435, 10.1073/pnas.1013246107 · DOI
  2. Amour, 1998, TNF-α converting enzyme (TACE) is inhibited by TIMP-3, FEBS Lett., 435, 39, 10.1016/S0014-5793(98)01031-X · DOI
  3. Amour, 2000, The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3, FEBS Lett., 473, 275, 10.1016/S0014-5793(00)01528-3 · DOI
  4. Baumeister, 1997, Human presenilin-1, but not familial Alzheimer’s disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing, Genes Funct., 1, 149, 10.1046/j.1365-4624.1997.00012.x · DOI
  5. Bennett, 2000, A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer’s β-secretase, J. Biol. Chem., 275, 37712, 10.1074/jbc.M005339200 · DOI
  6. Bozkulak, 2009, Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling, Mol. Cell. Biol., 29, 5679, 10.1128/MCB.00406-09 · DOI
  7. Brown, 2000, Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans, Cell, 100, 391, 10.1016/S0092-8674(00)80675-3 · DOI · Paper page
  8. Buxbaum, 1998, Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor, J. Biol. Chem., 273, 27765, 10.1074/jbc.273.43.27765 · DOI
  9. Caescu, 2009, Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10, Biochem. J., 424, 79, 10.1042/BJ20090549 · DOI
  10. Cao, 2001, A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60, Science, 293, 115, 10.1126/science.1058783 · DOI · Paper page
  11. Cao, 2004, Dissection of amyloid-β precursor protein-dependent transcriptional transactivation, J. Biol. Chem., 279, 24601, 10.1074/jbc.M402248200 · DOI
  12. Capell, 1998, The proteolytic fragments of the Alzheimer’s disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex, J. Biol. Chem., 273, 3205, 10.1074/jbc.273.6.3205 · DOI
  13. Capell, 2000, Maturation and pro-peptide cleavage of β-secretase, J. Biol. Chem., 275, 30849, 10.1074/jbc.M003202200 · DOI · Paper page
  14. Capell, 2005, γ-Secretase complex assembly within the early secretory pathway, J. Biol. Chem., 280, 6471, 10.1074/jbc.M409106200 · DOI
  15. Chang, 2007, Amyloid-β reduction by memapsin 2 (β-secretase) immunization, FASEB J., 21, 3184, 10.1096/fj.06-7993com · DOI
  16. Chavez-Gutierrez, 2008, Glu332 in the nicastrin ectodomain Is essential for γ-secretase complex maturation but not for its activity, J. Biol. Chem., 283, 20096, 10.1074/jbc.M803040200 · DOI
  17. Chen, 2006, TMP21 is a presenilin complex component that modulates γ-secretase but not ε-secretase activity, Nature, 440, 1208, 10.1038/nature04667 · DOI
  18. Chen, 2010, Aph-1 associates directly with full-length and C-terminal fragments of γ-secretase substrates, J. Biol. Chem., 285, 11378, 10.1074/jbc.M109.088815 · DOI
  19. Cheng, 2009, S-palmitoylation of γ-secretase subunits nicastrin and APH-1, J. Biol. Chem., 284, 1373, 10.1074/jbc.M806380200 · DOI
  20. Citron, 2010, Alzheimer’s disease: strategies for disease modification, Nat. Rev. Drug Discov., 9, 387, 10.1038/nrd2896 · DOI
  21. Citron, 1995, Generation of amyloid β protein from its precursor is sequence specific, Neuron, 14, 661, 10.1016/0896-6273(95)90323-2 · DOI
  22. Creemers, 2001, Processing of β-secretase by furin and other members of the proprotein convertase family, J. Biol. Chem., 276, 4211, 10.1074/jbc.M006947200 · DOI · Paper page
  23. Crystal, 2003, Membrane topology of γ-secretase component PEN-2, J. Biol. Chem., 278, 20117, 10.1074/jbc.M213107200 · DOI
  24. De Pietri Tonelli, 2004, Translational regulation of BACE-1 expression in neuronal and non-neuronal cells, Nucleic Acids Res., 32, 1808, 10.1093/nar/gkh348 · DOI
  25. Delarasse, 2011, The purinergic receptor P2X7 triggers α-secretase dependent processing of the amyloid precursor protein, J. Biol. Chem., 286, 2596, 10.1074/jbc.M110.200618 · DOI
  26. Dries, 2008, Assembly, maturation, and trafficking of the γ-secretase complex in Alzheimer’s disease, Curr. Alzheimer Res., 5, 132, 10.2174/156720508783954695 · DOI
  27. Dries, 2009, Glu-333 of nicastrin directly participates in γ-secretase activity, J. Biol. Chem., 284, 29714, 10.1074/jbc.M109.038737 · DOI
  28. Dulin, 2008, P3 peptide, a truncated form of Aβ devoid of synaptotoxic effect, does not assemble into soluble oligomers, FEBS Lett., 582, 1865, 10.1016/j.febslet.2008.05.002 · DOI
  29. Edbauer, 2002, Presenilin and nicastrin regulate each other and determine amyloid β-peptide production via complex formation, Proc. Natl Acad. Sci. USA, 99, 8666, 10.1073/pnas.132277899 · DOI
  30. Edbauer, 2003, Reconstitution of γ-secretase activity, Nat. Cell Biol., 5, 486, 10.1038/ncb960 · DOI
  31. Edwards, 2008, The ADAM metalloproteinases, Mol. Aspects Med., 29, 258, 10.1016/j.mam.2008.08.001 · DOI
  32. Esch, 1990, Cleavage of amyloid β peptide during constitutive processing of its precursor, Science, 248, 1122, 10.1126/science.2111583 · DOI
  33. Esler, 2000, Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1, Nat. Cell Biol., 2, 428, 10.1038/35017062 · DOI
  34. Esler, 2002, Activity-dependent isolation of the presenilin-γ-secretase complex reveals nicastrin and a γ substrate, Proc. Natl Acad. Sci. USA, 99, 2720, 10.1073/pnas.052436599 · DOI
  35. Faca, 2008, Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains, PLoS ONE, 3, 10.1371/journal.pone.0002425 · DOI
  36. Faghihi, 2008, Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of β-secretase, Nat. Med., 14, 723, 10.1038/nm1784 · DOI · Paper page
  37. Farmery, 2003, Partial purification and characterization of γ-secretase from post mortem human brain, J. Biol. Chem., 278, 24277, 10.1074/jbc.M211992200 · DOI
  38. Fassler, 2010, Masking of transmembrane-based retention signals controls ER export of γ-secretase, Traffic, 11, 250, 10.1111/j.1600-0854.2009.01014.x · DOI
  39. Ferrando, 2009, The role of NOTCH1 signaling in T-ALL, Hematology Am. Soc. Hematol. Educ. Program, 2009, 353, 10.1182/asheducation-2009.1.353 · DOI
  40. Fluhrer, 2006, A γ-secretase-like intramembrane cleavage of TNFα by the GxGD aspartyl protease SPPL2b, Nat. Cell Biol., 8, 894, 10.1038/ncb1450 · DOI
  41. Fluhrer, 2008, Intramembrane proteolysis of GXGD-type aspartyl proteases is slowed by a familial Alzheimer disease-like mutation, J. Biol. Chem., 283, 30121, 10.1074/jbc.M806092200 · DOI
  42. Fluhrer, 2009, Intramembrane proteolysis by signal peptide peptidases - a comparative discussion of GxGD-type aspartyl proteases, J. Biol. Chem., 284, 13975, 10.1074/jbc.R800040200 · DOI
  43. Fortini, 2009, Endocytic regulation of Notch signaling, Curr. Opin. Genet. Dev., 19, 323, 10.1016/j.gde.2009.04.005 · DOI
  44. Fortna, 2004, Membrane topology and nicastrin-enhanced endoproteolysis of APH-1, a component of the γ-secretase complex, J. Biol. Chem., 279, 3685, 10.1074/jbc.M310505200 · DOI
  45. Fraering, 2004, Detergent-dependent dissociation of active γ-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex, Biochemistry, 43, 323, 10.1021/bi035748j · DOI
  46. Francis, 2002, aph-1 and pen-2 are required for Notch pathway signaling, γ-secretase cleavage of βAPP, and presenilin protein accumulation, Dev. Cell, 3, 85, 10.1016/S1534-5807(02)00189-2 · DOI
  47. Freeman, 2009, Rhomboids: 7 years of a new protease family, Semin. Cell Dev. Biol., 20, 231, 10.1016/j.semcdb.2008.10.006 · DOI
  48. Friedmann, 2006, SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production, Nat. Cell Biol., 8, 843, 10.1038/ncb1440 · DOI
  49. Fukumori, 2010, Three-amino acid spacing of presenilin endoproteolysis suggests a general stepwise cleavage of γ-secretase-mediated intramembrane proteolysis, J. Neurosci., 30, 7853, 10.1523/JNEUROSCI.1443-10.2010 · DOI
  50. Furukawa, 1996, Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain, J. Neurochem., 67, 1882, 10.1046/j.1471-4159.1996.67051882.x · DOI
  51. Georgakopoulos, 2006, Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling, EMBO J., 25, 1242, 10.1038/sj.emboj.7601031 · DOI
  52. Golde, 2009, Signal peptide peptidases: a family of intramembrane-cleaving proteases that cleave type 2 transmembrane proteins, Semin. Cell Dev. Biol., 20, 225, 10.1016/j.semcdb.2009.02.003 · DOI
  53. Gruninger-Leitch, 2002, Substrate and inhibitor profile of BACE (β-secretase) and comparison with other mammalian aspartic proteases, J. Biol. Chem., 277, 4687, 10.1074/jbc.M109266200 · DOI · Paper page
  54. Gu, 2001, Distinct intramembrane cleavage of the β-amyloid precursor protein family resembling γ-secretase-like cleavage of Notch, J. Biol. Chem., 276, 35235, 10.1074/jbc.C100357200 · DOI
  55. Haass, 2004, Take five-BACE and the γ-secretase quartet conduct Alzheimer’s amyloid β-peptide generation, EMBO J., 23, 483, 10.1038/sj.emboj.7600061 · DOI
  56. Haass, 2002, Alzheimer disease γ-secretase: a complex story of GxGD-type presenilin proteases, Trends Cell Biol., 12, 556, 10.1016/S0962-8924(02)02394-2 · DOI
  57. Hartmann, 2002, The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for α-secretase activity in fibroblasts, Hum. Mol. Genet., 11, 2615, 10.1093/hmg/11.21.2615 · DOI
  58. Hayashida, 2010, Molecular and cellular mechanisms of ectodomain shedding, Anat. Rec. (Hoboken), 293, 925, 10.1002/ar.20757 · DOI
  59. He, 2010, γ-Secretase activating protein is a therapeutic target for Alzheimer’s disease, Nature, 467, 95, 10.1038/nature09325 · DOI
  60. Hebert, 2004, Coordinated and widespread expression of γ-secretase in vivo: evidence for size and molecular heterogeneity, Neurobiol. Dis., 17, 260, 10.1016/j.nbd.2004.08.002 · DOI
  61. Hebert, 2006, Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes, EMBO Rep., 7, 739, 10.1038/sj.embor.7400704 · DOI
  62. Hebert, 2008, Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/β-secretase expression, Proc. Natl Acad. Sci. USA, 105, 6415, 10.1073/pnas.0710263105 · DOI · Paper page
  63. Heilig, 2010, A presenilin-1 mutation identified in familial Alzheimer disease with cotton wool plaques causes a nearly complete loss of γ-secretase activity, J. Biol. Chem., 285, 22350, 10.1074/jbc.M110.116962 · DOI
  64. Hemming, 2008, Proteomic profiling of γ-secretase substrates and mapping of substrate requirements, PLoS Biol., 6, 10.1371/journal.pbio.0060257 · DOI · Paper page
  65. Henricson, 2005, A novel transmembrane topology of presenilin based on reconciling experimental and computational evidence, FEBS J., 272, 2727, 10.1111/j.1742-4658.2005.04691.x · DOI
  66. Hitt, 2010, BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization, Mol. Neurodegener., 5, 10.1186/1750-1326-5-31 · DOI · Paper page
  67. Hong, 2000, Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor, Science (New York, N.Y.), 290, 150, 10.1126/science.290.5489.150 · DOI
  68. Horiuchi, 2007, Cutting edge: TNF-α-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock, J. Immunol., 179, 2686, 10.4049/jimmunol.179.5.2686 · DOI
  69. Hu, 2006, Bace1 modulates myelination in the central and peripheral nervous system, Nat. Neurosci., 9, 1520, 10.1038/nn1797 · DOI · Paper page
  70. Huse, 2000, Maturation and endosomal targeting of β-site amyloid precursor protein-cleaving enzyme. The Alzheimer’s disease β-secretase, J. Biol. Chem., 275, 33729, 10.1074/jbc.M004175200 · DOI · Paper page
  71. Huse, 2002, β-Secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer’s disease brain, J. Biol. Chem., 14
  72. Hussain, 1999, Identification of a novel aspartic protease (Asp 2) as β-secretase, Mol. Cell. Neurosci., 14, 419, 10.1006/mcne.1999.0811 · DOI · Paper page
  73. Inoue, 2009, Synaptic activity prompts γ-secretase-mediated cleavage of EphA4 and dendritic spine formation, J. Cell Biol., 185, 551, 10.1083/jcb.200809151 · DOI
  74. Jacobsen, 1999, The influence of endoproteolytic processing of familial Alzheimer’s disease presenilin 2 on Aβ42 amyloid peptide formation, J. Biol. Chem., 274, 35233, 10.1074/jbc.274.49.35233 · DOI
  75. Janes, 2005, Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans, Cell, 123, 291, 10.1016/j.cell.2005.08.014 · DOI
  76. Jorissen, 2010, The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex, J. Neurosci., 30, 4833, 10.1523/JNEUROSCI.5221-09.2010 · DOI · Paper page
  77. Kaether, 2002, A presenilin-1/nicastrin complex is targeted to the plasma membrane and affects trafficking and processing of the β-amyloid precursor protein, J. Cell Biol., 158, 551, 10.1083/jcb.200201123 · DOI
  78. Kaether, 2007, Endoplasmic reticulum retention of the γ-secretase complex component Pen2 by Rer1, EMBO Rep., 8, 743, 10.1038/sj.embor.7401027 · DOI
  79. Kim, 2005, Evidence that the “NF” motif in transmembrane domain 4 of presenilin 1 is critical for binding with PEN-2, J. Biol. Chem., 280, 41953, 10.1074/jbc.M509070200 · DOI
  80. Kim, 2004, Evidence that assembly of an active γ-secretase complex occurs in the early compartments of the secretory pathway, J. Biol. Chem., 279, 48615, 10.1074/jbc.C400396200 · DOI
  81. Kimberly, 2000, The transmembrane aspartates in presenilin 1 and 2 are obligatory for γ-secretase activity and amyloid β-protein generation, J. Biol. Chem., 275, 3173, 10.1074/jbc.275.5.3173 · DOI
  82. Kimberly, 2003, γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2, Proc. Natl Acad. Sci. USA, 100, 6382, 10.1073/pnas.1037392100 · DOI
  83. Kitazume, 2002, Characterization of α 2,6-sialyltransferase cleavage by Alzheimer’s β-secretase(BACE1), J. Biol. Chem., 278, 14865, 10.1074/jbc.M206262200 · DOI
  84. Knappenberger, 2004, Mechanism of γ-secretase cleavage activation: is γ-secretase regulated through autoinhibition involving the presenilin-1 exon 9 loop?, Biochemistry, 43, 6208, 10.1021/bi036072v · DOI
  85. Kopan, 2009, The canonical Notch signaling pathway: unfolding the activation mechanism, Cell, 137, 216, 10.1016/j.cell.2009.03.045 · DOI
  86. Kornilova, 2005, The initial substrate-binding site of γ-secretase is located on presenilin near the active site, Proc. Natl Acad. Sci. USA, 102, 3230, 10.1073/pnas.0407640102 · DOI
  87. Kuhn, 2007, Regulated intramembrane proteolysis of the interleukin-1 receptor II by α-, β-, and γ-secretase, J. Biol. Chem., 282, 11982, 10.1074/jbc.M700356200 · DOI · Paper page
  88. Lammich, 1999, Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease, Proc. Natl. Acad. Sci., 96, 3922, 10.1073/pnas.96.7.3922 · DOI · Paper page
  89. Lammich, 2002, Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Aβ-like peptide, J. Biol. Chem., 277, 44754, 10.1074/jbc.M206872200 · DOI
  90. Lammich, 2004, Expression of the Alzheimer protease BACE1 is suppressed via its 5’-untranslated region, EMBO Rep., 5, 620, 10.1038/sj.embor.7400166 · DOI
  91. LaPointe, 2000, The type 4 prepilin peptidases comprise a novel family of aspartic acid proteases, J. Biol. Chem., 275, 1502, 10.1074/jbc.275.2.1502 · DOI
  92. Laudon, 2005, A nine-transmembrane domain topology for presenilin 1, J. Biol. Chem., 280, 35352, 10.1074/jbc.M507217200 · DOI
  93. Lazarov, 2006, Electron microscopic structure of purified, active γ-secretase reveals an aqueous intramembrane chamber and two pores, Proc. Natl Acad. Sci. USA, 103, 6889, 10.1073/pnas.0602321103 · DOI
  94. Le Gall, 2010, ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site, J. Cell Sci., 123, 3913, 10.1242/jcs.069997 · DOI
  95. Lee, 2002, Mammalian APH-1 interacts with presenilin and nicastrin and Is required for intramembrane proteolysis of amyloid-β precursor protein and Notch, J. Biol. Chem., 277, 45013, 10.1074/jbc.M208164200 · DOI
  96. Lemberg, 2007, Functional and evolutionary implications of enhanced genomic analysis of rhomboid intramembrane proteases, Genome Res., 17, 1634, 10.1101/gr.6425307 · DOI
  97. Levitan, 1996, Assessment of normal and mutant human presenilin function in Caenorhabditis elegans, Proc. Natl Acad. Sci. USA, 93, 14940, 10.1073/pnas.93.25.14940 · DOI
  98. Li, 2004, Cleavage of amyloid-β precursor protein and amyloid-β precursor-like protein by BACE 1, J. Biol. Chem., 279, 10542, 10.1074/jbc.M310001200 · DOI · Paper page
  99. Li, 2000a, Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state, Proc. Natl Acad. Sci. USA, 97, 6138, 10.1073/pnas.110126897 · DOI
  100. Li, 2000b, Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1, Nature, 405, 689, 10.1038/35015085 · DOI · Paper page
  101. Li, 2003, Nicastrin is required for assembly of presenilin/γ-secretase complexes to mediate Notch signaling and for processing and trafficking of β-amyloid precursor protein in mammals, J. Neurosci., 23, 3272, 10.1523/JNEUROSCI.23-08-03272.2003 · DOI
  102. Lichtenthaler, 2011, α-Secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential, J. Neurochem., 116, 10, 10.1111/j.1471-4159.2010.07081.x · DOI
  103. Lichtenthaler, 2007, Sheddases and intramembrane-cleaving proteases: RIPpers of the membrane. Symposium on regulated intramembrane proteolysis, EMBO Rep., 8, 537, 10.1038/sj.embor.7400978 · DOI
  104. Lichtenthaler, 2003, The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1, J. Biol. Chem., 278, 48713, 10.1074/jbc.M303861200 · DOI · Paper page
  105. Lin, 2000, Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein, Proc. Natl Acad. Sci. USA, 97, 1456, 10.1073/pnas.97.4.1456 · DOI
  106. Ludwig, 2005, Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules, Comb. Chem. High Throughput Screen, 8, 161, 10.2174/1386207053258488 · DOI
  107. Martin, 2009, Substrate requirements for SPPL2b-dependent regulated intramembrane proteolysis, J. Biol. Chem., 284, 5662, 10.1074/jbc.M807485200 · DOI
  108. McCarthy, 2009, Presenilin-dependent regulated intramembrane proteolysis and γ-secretase activity, Cell. Mol. Life Sci., 66, 1534, 10.1007/s00018-009-8435-9 · DOI
  109. Meziane, 1998, Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice, Proc. Natl Acad. Sci. USA, 95, 12683, 10.1073/pnas.95.21.12683 · DOI
  110. Mitterreiter, 2010, Bepridil and amiodarone simultaneously target the Alzheimer’s disease β- and γ-secretase via distinct mechanisms, J. Neurosci., 30, 8974, 10.1523/JNEUROSCI.1199-10.2010 · DOI
  111. Moehlmann, 2002, Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production, Proc. Natl Acad. Sci. USA, 99, 8025, 10.1073/pnas.112686799 · DOI
  112. Morais, 2003, The transmembrane domain region of nicastrin mediates direct interactions with APH-1 and the γ-secretase complex, J. Biol. Chem., 278, 43284, 10.1074/jbc.M305685200 · DOI
  113. Munter, 2007, GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42, EMBO J., 26, 1702, 10.1038/sj.emboj.7601616 · DOI
  114. Munter, 2010, Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif, J. Biol. Chem., 285, 21636, 10.1074/jbc.M109.088005 · DOI
  115. Nagano, 2004, Mechanism and biological significance of CD44 cleavage, Cancer Sci., 95, 930, 10.1111/j.1349-7006.2004.tb03179.x · DOI
  116. Nikolaev, 2009, APP binds DR6 to trigger axon pruning and neuron death via distinct caspases, Nature, 457, 981, 10.1038/nature07767 · DOI · Paper page
  117. Nyabi, 2003, Presenilins mutated at Asp257 or Asp385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin, J. Biol. Chem., 278, 43430, 10.1074/jbc.M306957200 · DOI
  118. O’Connor, 2008, Phosphorylation of the translation initiation factor eIF2α increases BACE1 levels and promotes amyloidogenesis, Neuron, 60, 988, 10.1016/j.neuron.2008.10.047 · DOI
  119. Oh, 2005a, Topology of the C-terminal fragment of human presenilin 1, Biochemistry, 44, 11821, 10.1021/bi0509494 · DOI
  120. Oh, 2005b, Evidence that the COOH terminus of human presenilin 1 is located in extracytoplasmic space, Am. J. Physiol. Cell Physiol., 289, C576, 10.1152/ajpcell.00636.2004 · DOI
  121. Okochi, 2002, Presenilins mediate a dual intramembraneous γ-secretase cleavage of Notch-1, EMBO J., 21, 5408, 10.1093/emboj/cdf541 · DOI
  122. Osenkowski, 2009, Cryoelectron microscopy structure of purified γ-secretase at 12 Å resolution, J. Mol. Biol., 385, 642, 10.1016/j.jmb.2008.10.078 · DOI
  123. Parkin, 2009, A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10, J. Neurochem., 108, 1464, 10.1111/j.1471-4159.2009.05907.x · DOI
  124. Perez-Revuelta, 2010, Requirement for small side chain residues within the GxGD-motif of presenilin for γ-secretase substrate cleavage, J. Neurochem., 112, 940, 10.1111/j.1471-4159.2009.06510.x · DOI
  125. Peschon, 1998, An essential role for ectodomain shedding in mammalian development, Science, 282, 1281, 10.1126/science.282.5392.1281 · DOI
  126. Podlisny, 1997, Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue, Neurobiol. Dis., 3, 325, 10.1006/nbdi.1997.0129 · DOI
  127. Postina, 2004, A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model, J. Clin. Invest., 113, 1456, 10.1172/JCI20864 · DOI · Paper page
  128. Qi-Takahara, 2005, Longer forms of amyloid β protein: implications for the mechanism of intramembrane cleavage by γ-secretase, J. Neurosci., 25, 436, 10.1523/JNEUROSCI.1575-04.2005 · DOI · Paper page
  129. Rajendran, 2008, Efficient inhibition of the Alzheimer’s disease β-secretase by membrane targeting, Science, 320, 520, 10.1126/science.1156609 · DOI
  130. Reiss, 2009, The “A Disintegrin And Metalloprotease” (ADAM) family of sheddases: physiological and cellular functions, Semin. Cell Dev. Biol., 20, 126, 10.1016/j.semcdb.2008.11.002 · DOI
  131. Ren, 2007, Amyloid β-protein precursor juxtamembrane domain regulates specificity of γ-secretase-dependent cleavages, J. Biol. Chem., 282, 35350, 10.1074/jbc.M702739200 · DOI
  132. Ring, 2007, The secreted β-amyloid precursor protein ectodomain APPsα is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice, J. Neurosci., 27, 7817, 10.1523/JNEUROSCI.1026-07.2007 · DOI · Paper page
  133. Rogers, 2004, Differential utilization of upstream AUGs in the β-secretase mRNA suggests that a shunting mechanism regulates translation, Proc. Natl Acad. Sci. USA, 101, 2794, 10.1073/pnas.0308576101 · DOI
  134. Rossner, 2006, Transcriptional and translational regulation of BACE1 expression-implications for Alzheimer’s disease, Prog. Neurobiol., 79, 95, 10.1016/j.pneurobio.2006.06.001 · DOI
  135. Sannerud, 2009, Trafficking, a key player in regulated intramembrane proteolysis, Semin. Cell Dev. Biol., 20, 183, 10.1016/j.semcdb.2008.11.004 · DOI
  136. Sastre, 2001, Presenilin-dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch, EMBO Rep., 2, 835, 10.1093/embo-reports/kve180 · DOI
  137. Sato, 2006, Structure of the catalytic pore of γ-secretase probed by the accessibility of substituted cysteines, J. Neurosci., 26, 12081, 10.1523/JNEUROSCI.3614-06.2006 · DOI
  138. Sato, 2007, Active γ-secretase complexes contain only one of each component, J. Biol. Chem., 282, 33985, 10.1074/jbc.M705248200 · DOI
  139. Sato, 2008a, The C-terminal PAL motif and transmembrane domain 9 of presenilin 1 are involved in the formation of the catalytic pore of the γ-secretase, J. Neurosci., 28, 6264, 10.1523/JNEUROSCI.1163-08.2008 · DOI
  140. Sato, 2008b, Distinct pharmacological effects of inhibitors of signal peptide peptidase and γ-secretase, J. Biol. Chem., 283, 33287, 10.1074/jbc.M805670200 · DOI
  141. Saunders, 1999, BACE maps to chromosome 11 and a BACE homolog, BACE2, reside in the obligate down syndrome region of chromosome 21, Science, 286, 10.1126/science.286.5443.1255a · DOI
  142. Schmechel, 2004, Human BACE forms dimers and colocalizes with APP, J. Biol. Chem., 279, 39710, 10.1074/jbc.M402785200 · DOI
  143. Schroeter, 2003, A presenilin dimer at the core of the γ-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis, Proc. Natl Acad. Sci. USA, 100, 13075, 10.1073/pnas.1735338100 · DOI
  144. Seeger, 1997, Evidence for phosphorylation and oligomeric assembly of presenilin 1, Proc. Natl Acad. Sci. USA, 94, 5090, 10.1073/pnas.94.10.5090 · DOI
  145. Seiffert, 2000, Presenilin-1 and -2 are molecular targets for γ-secretase inhibitors, J. Biol. Chem., 275, 34086, 10.1074/jbc.M005430200 · DOI
  146. Selkoe, 2003, Notch and presenilin: regulated intramembrane proteolysis links development and degeneration, Annu. Rev. Neurosci., 26, 565, 10.1146/annurev.neuro.26.041002.131334 · DOI
  147. Serneels, 2009, γ-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer’s disease, Science, 324, 639, 10.1126/science.1171176 · DOI
  148. Shah, 2005, Nicastrin functions as a γ-secretase-substrate receptor, Cell, 122, 435, 10.1016/j.cell.2005.05.022 · DOI
  149. Shimojo, 2008, Enzymatic characteristics of I213T mutant presenilin-1/γ-secretase in cell models and knock-in mouse brains: familial Alzheimer disease-linked mutation impairs γ-site cleavage of amyloid precursor protein C-terminal fragment β, J. Biol. Chem., 283, 16488, 10.1074/jbc.M801279200 · DOI
  150. Shirotani, 1997, Determination of a cleavage site of presenilin 2 protein in stably transfected SH-SY5Y human neuroblastoma cell lines, Biochem. Biophys. Res. Commun., 240, 728, 10.1006/bbrc.1997.7730 · DOI
  151. Shirotani, 2000, Mutational analysis of intrinsic regions of presenilin 2 that determine its endoproteolytic cleavage and pathological function, J. Biol. Chem., 275, 3681, 10.1074/jbc.275.5.3681 · DOI
  152. Shirotani, 2004a, Identification of distinct γ-secretase complexes with different APH-1 variants, J. Biol. Chem., 279, 41340, 10.1074/jbc.M405768200 · DOI
  153. Shirotani, 2004b, Immature nicastrin stabilizes APH-1 independent of PEN-2 and presenilin - identification of nicastrin mutants which selectively interact with APH-1, J. Neurochem., 89, 1520, 10.1111/j.1471-4159.2004.02447.x · DOI
  154. Shirotani, 2007, Pathological activity of familial Alzheimer’s disease-associated mutant presenilin can be executed by six different γ-secretase complexes, Neurobiol. Dis., 27, 102, 10.1016/j.nbd.2007.04.011 · DOI
  155. Sinha, 1999, Purification and cloning of amyloid precursor protein β-secretase from human brain, Nature, 402, 537, 10.1038/990114 · DOI · Paper page
  156. Sisodia, 1992, β-Amyloid precursor protein cleavage by a membrane-bound protease, Proc. Natl Acad. Sci. USA, 89, 6075, 10.1073/pnas.89.13.6075 · DOI
  157. Skovronsky, 2000, Protein kinase C-dependent α-secretase competes with β-secretase for cleavage of amyloid-β precursor protein in the trans-golgi network, J. Biol. Chem., 275, 2568, 10.1074/jbc.275.4.2568 · DOI
  158. Sobhanifar, 2010, Structural investigation of the C-terminal catalytic fragment of presenilin 1, Proc. Natl Acad. Sci. USA, 107, 9644, 10.1073/pnas.1000778107 · DOI
  159. Solans, 2000, A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer’s amyloid precursor protein β-secretase, Cytogenet. Cell Genet., 89, 177, 10.1159/000015608 · DOI
  160. Song, 1999, Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations, Proc. Natl Acad. Sci. USA, 96, 6959, 10.1073/pnas.96.12.6959 · DOI · Paper page
  161. Spasic, 2008, Building γ-secretase: the bits and pieces, J. Cell Sci., 121, 413, 10.1242/jcs.015255 · DOI
  162. Spasic, 2006, Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway, J. Biol. Chem., 281, 26569, 10.1074/jbc.M600592200 · DOI
  163. Spasic, 2007, Rer1p competes with APH-1 for binding to nicastrin and regulates γ-secretase complex assembly in the early secretory pathway, J. Cell Biol., 176, 629, 10.1083/jcb.200609180 · DOI
  164. Steiner, 1998, The proprotein convertases, Curr. Opin. Chem. Biol., 2, 31, 10.1016/S1367-5931(98)80033-1 · DOI
  165. Steiner, 1999a, Amyloidogenic function of the Alzheimer’s disease-associated presenilin 1 in the absence of endoproteolysis, Biochemistry, 38, 14600, 10.1021/bi9914210 · DOI
  166. Steiner, 1999b, A loss of function mutation of presenilin-2 interferes with amyloid β-peptide production and Notch signaling, J. Biol. Chem., 274, 28669, 10.1074/jbc.274.40.28669 · DOI
  167. Steiner, 2000, Glycine 384 is required for presenilin-1 function and is conserved in polytopic bacterial aspartyl proteases, Nat. Cell Biol., 2, 848, 10.1038/35041097 · DOI
  168. Steiner, 2002, PEN-2 is an integral component of the γ-secretase complex required for coordinated expression of presenilin and nicastrin, J. Biol. Chem., 277, 39062, 10.1074/jbc.C200469200 · DOI
  169. Steiner, 2008, Chemical cross-linking provides a model of the γ-secretase complex subunit architecture and evidence for close proximity of the C-terminal fragment of presenilin with APH-1, J. Biol. Chem., 283, 34677, 10.1074/jbc.M709067200 · DOI
  170. Struhl, 2000, Requirements for presenilin-dependent cleavage of Notch and other transmembrane proteins, Mol. Cell, 6, 625, 10.1016/S1097-2765(00)00061-7 · DOI
  171. Takagi, 2010, Participation of transmembrane domain 1 of presenilin 1 in the catalytic pore structure of the γ-secretase, J. Neurosci., 30, 15943, 10.1523/JNEUROSCI.3318-10.2010 · DOI
  172. Takami, 2009, γ-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment, J. Neurosci., 29, 13042, 10.1523/JNEUROSCI.2362-09.2009 · DOI · Paper page
  173. Takasugi, 2003, The role of presenilin cofactors in the γ-secretase complex, Nature, 422, 438, 10.1038/nature01506 · DOI
  174. van Tetering, 2009, Metalloprotease ADAM10 is required for Notch1 site 2 cleavage, J. Biol. Chem., 284, 31018, 10.1074/jbc.M109.006775 · DOI
  175. Thinakaran, 1996, Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo, Neuron, 17, 181, 10.1016/S0896-6273(00)80291-3 · DOI
  176. Thinakaran, 1998, Stable association of presenilin derivatives and absence of presenilin interactions with APP, Neurobiol. Dis., 4, 438, 10.1006/nbdi.1998.0171 · DOI
  177. Tolia, 2006, Contribution of presenilin transmembrane domains 6 and 7 to a water-containing cavity in the γ-secretase complex, J. Biol. Chem., 281, 27633, 10.1074/jbc.M604997200 · DOI
  178. Tolia, 2008, Transmembrane domain 9 of presenilin determines the dynamic conformation of the catalytic site of γ-secretase, J. Biol. Chem., 283, 19793, 10.1074/jbc.M802461200 · DOI
  179. Tomita, 2009, Secretase inhibitors and modulators for Alzheimer’s disease treatment, Expert Rev. Neurother., 9, 661, 10.1586/ern.09.24 · DOI
  180. Tousseyn, 2009, ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the γ-secretase, J. Biol. Chem., 284, 11738, 10.1074/jbc.M805894200 · DOI
  181. Vassar, 2009, The β-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential, J. Neurosci., 29, 12787, 10.1523/JNEUROSCI.3657-09.2009 · DOI · Paper page
  182. Wakabayashi, 2009, Analysis of the γ-secretase interactome and validation of its association with tetraspanin-enriched microdomains, Nat. Cell Biol., 11, 1340, 10.1038/ncb1978 · DOI · Paper page
  183. Wang, 2006a, C-terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation, J. Neurochem., 96, 218, 10.1111/j.1471-4159.2005.03548.x · DOI
  184. Wang, 2006b, Crystal structure of a rhomboid family intramembrane protease, Nature, 444, 179, 10.1038/nature05255 · DOI
  185. Wang, 2008, The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of β-site amyloid precursor protein-cleaving enzyme 1, J. Neurosci., 28, 1213, 10.1523/JNEUROSCI.5065-07.2008 · DOI · Paper page
  186. Watanabe, 2005, Pen-2 is incorporated into the γ-secretase complex through binding to transmembrane domain 4 of presenilin 1, J. Biol. Chem., 280, 41967, 10.1074/jbc.M509066200 · DOI
  187. Weidemann, 2002, A novel ε-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing, Biochemistry, 41, 2825, 10.1021/bi015794o · DOI
  188. Weihofen, 2002, Identification of signal peptide peptidase, a presenilin-type aspartic protease, Science, 296, 2215, 10.1126/science.1070925 · DOI
  189. Westmeyer, 2004, Dimerization of β-site β-amyloid precursor protein-cleaving enzyme, J. Biol. Chem., 279, 53205, 10.1074/jbc.M410378200 · DOI
  190. Willem, 2009, Function, regulation and therapeutic properties of β-secretase (BACE1), Semin. Cell Dev. Biol., 20, 175, 10.1016/j.semcdb.2009.01.003 · DOI
  191. Willems, 2010, Thiol isomerases negatively regulate the cellular shedding activity of ADAM17, Biochem. J., 428, 439, 10.1042/BJ20100179 · DOI
  192. Winkler, 2009, Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human γ-secretase, Biochemistry, 48, 1183, 10.1021/bi801204g · DOI
  193. Wolfe, 1999, Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity, Nature, 398, 513, 10.1038/19077 · DOI
  194. Wong, 2005, β Subunits of voltage-gated sodium channels are novel substrates of β-site amyloid precursor protein-cleaving enzyme (BACE1) and γ-secretase, J. Biol. Chem., 280, 23009, 10.1074/jbc.M414648200 · DOI
  195. Wu, 2006, Structural analysis of a rhomboid family intramembrane protease reveals a gating mechanism for substrate entry, Nat. Struct. Mol. Biol., 13, 1084, 10.1038/nsmb1179 · DOI
  196. Xu, 2010, Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation, Mol. Cell, 37, 551, 10.1016/j.molcel.2010.01.034 · DOI
  197. Yamasaki, 2006, The GxGD motif of presenilin contributes to catalytic function and substrate identification of γ-secretase, J. Neurosci., 26, 3821, 10.1523/JNEUROSCI.5354-05.2006 · DOI
  198. Yan, 1999, Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase activity, Nature, 402, 533, 10.1038/990107 · DOI · Paper page
  199. Yanagida, 2009, The 28-amino acid form of an APLP1-derived Aβ-like peptide is a surrogate marker for Aβ42 production in the central nervous system, EMBO Mol. Med., 1, 223, 10.1002/emmm.200900026 · DOI
  200. Yu, 1998, The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin, J. Biol. Chem., 273, 16470, 10.1074/jbc.273.26.16470 · DOI

200 of 206 shown

Cited by

Sorted by citations

Metadata

Authors
Lichtenthaler, S. F., Haass, C., & Steiner, H.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2011-04-14
Volume
117
Issue
5
Pages
779-796
ISSN
0022-3042
Cited by
205
References
13
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review